Houston Methodist

Projects

Projects per year 2000 2013 2016 2018 2019 2020 2021 2022 2023 2024 2046

• 192 Not started
• 536 Active
• 818 Finished

Projects per year

Search results

• Active

  The Microbiome and Mucosal Immunity in Cervical Cancer Disparities

  Cullen, J. (PI)

  4/1/24 → 3/31/27

  Project: Federal Funding Agencies

• Development and Translation of Advanced Motion Correction Technologies for Cardiac PET/CT

  Al-Mallah, M. (PI)

  4/1/24 → 3/31/28

  Project: Federal Funding Agencies

• CAR T Cells for Advanced Thyroid Cancer

  Jin, M. M. (PI)

  4/1/24 → 3/31/26

  Project: Federal Funding Agencies

• ACS Transportation Grant-Renewal

  4/1/24 → 3/31/25

  Project: Non Profit

• Validating Novel Biologic Mediators and Therapeutic Targets in t(4;14) Myeloma

  Yi, Q. (PI)

  4/1/24 → 4/1/27

  Project: Non Profit

• Administrative Type 4 application ? Grant Number: 4R01NS118584 - 02 PI Age-related TDP-43 neuropathology in human amygdala: using disease-driving mechanisms to guide classification

  Cykowski, M. D. (PI)

  4/1/24 → 3/31/25

  Project: Federal Funding Agencies

• A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician?s Choice in Participants With Endometrial Cancer and Immunotherapy (ENGOT-en23/GOG3095)?

  Ramirez, P. T. (PI)

  3/28/24 → 3/27/34

  Project: Non Profit

• A 12-Month, Randomized, Open-Label, Phase IIA Study Evaluating the Safety and Efficacy of Siplizumab in Combination with Belatacept and MPA Compared to Standard of Care Immunosuppression in de novo Renal Transplant Recipients (ASCEND)

  Knight, R. J. (PI), Gaber, A. O. (Key Personnel) & Yi, S. (Key Personnel)

  3/22/24 → …

  Project: Clinical Trial

• Dysfunctional High Density Lipoprotein Free Cholesterol Bioavailability and Atherogenesis

  Pownall, H. J. (PI), Gillard, B. K. (Key Personnel), Nasir, K. (Key Personnel), Patel, K. V. (Key Personnel) & Rosales, C. (Key Personnel)

  3/21/24 → …

  Project: Clinical Trial

• ConductIoN System pacInG witH IngeviTy+ for the Left Bundle Branch Area (INSIGHT-LBBA)

  3/21/24 → 3/20/34

  Project: Non Profit

• Open-Label, Multicenter, Phase 1 Study to Assess the Safety of P-BCMA-ALLO1 in Subjects with Relapsed / Refractory Multiple Myeloma (MM)

  Ganguly, S. (PI), Mai, H. P. (Key Personnel), Pingali, S. R. (Key Personnel) & Shah, S. (Key Personnel)

  3/21/24 → …

  Project: Clinical Trial

• Observational study to compare the effectiveness of Ceftazidime-Avibactam versus Ceftolozane-Tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the United States (CACTUS)

  Miller, W. R. (PI)

  3/18/24 → 3/17/34

  Project: Non Profit

• Randomized Controlled Trial Comparing NEUROMARK System to Sham Control in Patients With Chronic Rhinitis

  Takashima, M. (PI) & Ahmed, O. G. (Key Personnel)

  3/7/24 → …

  Project: Clinical Trial

• Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

  Ramirez, P. T. (PI), Alaniz, A. (Key Personnel), Kamat, A. A. (Key Personnel), Suri, A. (Key Personnel) & Zaid, T. (Key Personnel)

  3/7/24 → …

  Project: Clinical Trial

• Non-invasive Identification of Cardiac Conduction System Abnormalities in a Myotonic Dystrophy Model

  Filgueira, C. S. (PI)

  3/1/24 → 2/28/26

  Project: Federal Funding Agencies

• Combination Therapy Using ATRA and Carfilzomib to Treat Proteasome Inhibitor Refractory Multiple Myeloma

  Yi, Q. (PI)

  3/1/24 → 2/28/28

  Project: State

• Cancer Prevention and Outreach for Individuals Disproportionately Affected by Cancer in Medically Underserved Regions (C-CUR)

  Esnaola, N. F. (PI)

  3/1/24 → 2/28/27

  Project: Non Profit

• Optogenetic manipulation of cortical feedback to examine network function and behavior

  Dragoi, V. (PI)

  2/19/24 → 3/31/25

  Project: Federal Funding Agencies

• A Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants with Amyotrophic Lateral Sclerosis

  Shroff, S. (PI)

  2/16/24 → 12/31/25

  Project: Non Profit

• Neural coding of natural stimuli in freely moving macaque

  Dragoi, V. (PI)

  2/15/24 → 6/30/25

  Project: Federal Funding Agencies

• Endoscopic sleeve gastroplasty (ESG) for the treatment of obesity

  McCarty, T. R. (PI) & Tariq, N. (Key Personnel)

  2/9/24 → …

  Project: Clinical Trial

• Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis

  You, M. (PI)

  2/2/24 → 1/31/29

  Project: Federal Funding Agencies

• Novel platform technologies for RNA vaccines WP1: Design of vaccine candidates

  Cooke, J. P. (PI)

  2/1/24 → 7/31/25

  Project: Non Profit

• Novel platform technologies for RNA vaccines WP3: Preclinical small animal

  Cooke, J. P. (PI)

  2/1/24 → 7/31/25

  Project: Non Profit

• Novel platform technologies for RNA vaccines WP2: Optimization of CircRNA

  Cooke, J. P. (PI)

  2/1/24 → 7/31/25

  Project: Non Profit

• Novel platform technologies for RNA vaccines WP5: Large animal efficacy studies

  Cooke, J. P. (PI)

  2/1/24 → 7/31/25

  Project: Non Profit

• Novel platform technologies for RNA vaccines WP4:GMP production small scale

  Cooke, J. P. (PI)

  2/1/24 → 7/31/25

  Project: Non Profit

• Impact of Irreversible T Cell Dysfunction on Transplant Outcomes

  Chen, W. (PI)

  1/12/24 → 12/31/24

  Project: Federal Funding Agencies

• A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER TRIAL OF SELINEXOR IN MAINTENANCE THERAPY AFTER SYSTEMIC THERAPY FOR PATIENTS WITH P53WILD-TYPE, ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA.

  Ramirez, P. T. (PI)

  1/10/24 → 1/9/34

  Project: Non Profit

• Patterned optogenetic neuromodulation to reprogram glioma stem cells

  Rostomily, R. C. (PI)

  1/9/24 → 12/31/25

  Project: Federal Funding Agencies

• Higher neural and clinical effects of transcranial magnetic stimulation for overactive bladder

  High, R. A. (PI), Antosh, D. (Key Personnel), Gonzalez, R. (Key Personnel), Helekar, S. (Key Personnel) & Khavari, R. (Key Personnel)

  1/5/24 → …

  Project: Clinical Trial

• Tumor-specific CD8+ Tc9 cells activate host CD4+ T cells to control antigen-lost tumors

  Yi, Q. (PI)

  1/1/24 → 12/31/28

  Project: Federal Funding Agencies

• Eradication of Advanced Prostate Cancer by Chimeric Antigen Receptor-T Cell Therapy with A Safety Switch

  He, B. (PI)

  1/1/24 → 12/31/25

  Project: Non Profit

• Breast Cancer Screening & Diagnostics for Black Individuals in the Houston Area (Susan G. Komen)

  Chang, J. C. (PI)

  1/1/24 → 12/31/24

  Project: Non Profit

• Lipid Metabolism Controlled Hematopoiesis and Atherosclerosis.

  Fang, L. (PI)

  1/1/24 → 12/31/25

  Project: Non Profit

• Adherence Determinants in the Health Electronic Record Evaluation of Statins (ADHERES)

  Nasir, K. (PI)

  12/15/23 → 11/30/28

  Project: Federal Funding Agencies

• Special Initiative Participation Incentive Agreement Lp(a) Discovery Project

  Nasir, K. (PI)

  12/1/23 → 11/30/26

  Project: Non Profit

• The Impact of Sleep on Network Coding and Perceptual Performance

  Dragoi, V. (PI)

  12/1/23 → 12/31/25

  Project: Federal Funding Agencies

• A Phase III, adjudicator-blinded, randomised study to evaluate the efficacy and safety of treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with invasive fungal disease (IFD) caused by Aspergillus species

  Grimes, K. A. (PI), Lin, J. (Key Personnel), Malik, A. I. (Key Personnel) & Nigo, M. (Key Personnel)

  11/16/23 → …

  Project: Clinical Trial

• CAMBRIA-1: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Extended Therapy with Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) versus Standard Endocrine

  11/6/23 → 11/5/33

  Project: Non Profit

• Increased nerve activity during apnea promotes triggers and pro-arrhythmic substrate which contributes to increased susceptibility to AF in patients with concomitant sleep apnea

  Valderrábano, M. (PI), Dave, A. (Key Personnel), Kleiman, N. (Key Personnel) & Lador, A. (Key Personnel)

  11/1/23 → …

  Project: Clinical Trial

• Collaborative Research: FW-HTF-RM: Robotic Teaching Assistant Systems for Nursing Instructors

  Hamlin, S. K. (PI)

  11/1/23 → 10/31/27

  Project: Federal Funding Agencies

• Harnessing neuroplasticity of postural sensorimotor networks using non-invasive spinal neuromodulation to maximize functional recovery after spinal cord injury

  Sayenko, D. (PI), Barber, S. (Key Personnel), Faraji, A. (Key Personnel), Horner, P. J. (Key Personnel), Kaldis, T. (Key Personnel) & Mathur, S. (Key Personnel)

  10/27/23 → …

  Project: Clinical Trial

• The ANTAEUS Platform

  Gollihar, J. D. (PI)

  10/13/23 → 10/12/28

  Project: Federal Funding Agencies

• Specialty societies advancing adult immunizations in patients with diabetes

  Sadhu, A. (PI)

  10/1/23 → 9/30/25

  Project: Federal Funding Agencies

• Novel potential drug targets for treatment of triple-negative breast cancer

  Chang, J. C. (PI)

  10/1/23 → 9/30/25

  Project: Non Profit

• A transformative platform to combat antibiotic resistant bacteria.

  Mylonakis, E. (PI)

  9/26/23 → 9/25/28

  Project: Federal Funding Agencies

• PK-RNN-V - Deep-Learning Based Pharmacokinetic Model for Vancomycin

  Nigo, M. (PI)

  9/21/23 → 7/31/28

  Project: Federal Funding Agencies

• Spinal Neuromodulation to Promote Physiologic and Molecular Plasticity in the Injured Spinal Cord

  Horner, P. J. (PI)

  9/20/23 → 8/31/28

  Project: Federal Funding Agencies

• Pharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment response?

  Rostomily, R. C. (PI)

  9/19/23 → 8/31/28

  Project: Federal Funding Agencies